Improved Visual Outcome and Low Recurrence with Early Treatment with Intravitreal Anti-Vascular Endothelial Growth Factor in Myopic Choroidal Neovascularization

Publisher： Karger

E-ISSN： 1423-0267|237|3|128-138

ISSN： 0030-3755

Source： Ophthalmologica, Vol.237, Iss.3, 2017-03, pp. : 128-138

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Two-Year Results of Photodynamic Therapy Combined with Intravitreal Anti-Vascular Endothelial Growth Factor for Polypoidal Choroidal Vasculopathy

By  

Ophthalmologica, Vol. 226, Iss. 4, 2011-09 ,pp. : 205-213

Karger

Access to resources Recommend Favorite

Two-Year Outcome after Combination Therapy for Polypoidal Choroidal Vasculopathy: Comparison with Photodynamic Monotherapy and Anti-Vascular Endothelial Growth Factor Monotherapy

By  

Ophthalmologica, Vol. 231, Iss. 2, 2013-10 ,pp. : 86-93

Karger

Access to resources Recommend Favorite

Effect of Intravitreal Anti-Vascular Endothelial Growth Factor Treatment on the Retinal Gene Expression in Acute Experimental Central Retinal Vein Occlusion

By  

Ophthalmic Research, Vol. 47, Iss. 3, 2011-11 ,pp. : 157-162

Karger

Access to resources Recommend Favorite

Anti-Vascular Endothelial Growth Factor Treatment for Retinal Vein Occlusions

By  

Ophthalmologica, Vol. 227, Iss. 1, 2012-04 ,pp. : 30-35

Karger

Access to resources Recommend Favorite

Evaluation of the Incidence of Endophthalmitis after Intravitreal Injection of Anti-Vascular Endothelial Growth Factor

By  

Ophthalmologica, Vol. 226, Iss. 3, 2011-07 ,pp. : 145-150

Karger

Access to resources Recommend Favorite